Global Psychedelic Drugs Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Psychedelic Drugs Industry Forecast” looks at past sales and reviews total world Psychedelic Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Psychedelic Drugs sales for 2023 through 2029. With Psychedelic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Psychedelic Drugs industry.
This Insight Report provides a comprehensive analysis of the global Psychedelic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Psychedelic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Psychedelic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Psychedelic Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Psychedelic Drugs.
The global Psychedelic Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Psychedelic Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Psychedelic Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Psychedelic Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Psychedelic Drugs players cover COMPASS Pathways PLC, Pfizer, Eli Lilly, GlaxoSmithKline, Cybin Inc, Field Trip Health, ATAI Life Sciences, NUMINUS WELLNESS and MindMed, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Psychedelic Drugs market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Psychedelic Drugs Industry Forecast” looks at past sales and reviews total world Psychedelic Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Psychedelic Drugs sales for 2023 through 2029. With Psychedelic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Psychedelic Drugs industry.
This Insight Report provides a comprehensive analysis of the global Psychedelic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Psychedelic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Psychedelic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Psychedelic Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Psychedelic Drugs.
The global Psychedelic Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Psychedelic Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Psychedelic Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Psychedelic Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Psychedelic Drugs players cover COMPASS Pathways PLC, Pfizer, Eli Lilly, GlaxoSmithKline, Cybin Inc, Field Trip Health, ATAI Life Sciences, NUMINUS WELLNESS and MindMed, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Psychedelic Drugs market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- Others
- Depressive Disorders
- Post-Traumatic Stress Disorders
- Substance Abuse Disorders
- Obsessive Compulsive Disorders
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- COMPASS Pathways PLC
- Pfizer
- Eli Lilly
- GlaxoSmithKline
- Cybin Inc
- Field Trip Health
- ATAI Life Sciences
- NUMINUS WELLNESS
- MindMed
- HAVN Life Sciences
- Seelos Therapeutics
- Jannsen
- Acadia Pharmaceuticals
- Intellipharmaceutics
- Revive Therapeutics
- Mydecine Innovations Group
- Red Light Holland
- Braxia Scientific
- Mind Cure Health
- Entheon Biomedical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psychedelic Drugs Market Size 2018-2029
2.1.2 Psychedelic Drugs Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Psychedelic Drugs Segment by Type
2.2.1 Psilocybin
2.2.2 LSD
2.2.3 MDMA
2.2.4 DMT
2.2.5 Ketamine
2.2.6 Others
2.3 Psychedelic Drugs Market Size by Type
2.3.1 Psychedelic Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Psychedelic Drugs Market Size Market Share by Type (2018-2023)
2.4 Psychedelic Drugs Segment by Application
2.4.1 Depressive Disorders
2.4.2 Post-Traumatic Stress Disorders
2.4.3 Substance Abuse Disorders
2.4.4 Obsessive Compulsive Disorders
2.4.5 Others
2.5 Psychedelic Drugs Market Size by Application
2.5.1 Psychedelic Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Psychedelic Drugs Market Size Market Share by Application (2018-2023)
3 PSYCHEDELIC DRUGS MARKET SIZE BY PLAYER
3.1 Psychedelic Drugs Market Size Market Share by Players
3.1.1 Global Psychedelic Drugs Revenue by Players (2018-2023)
3.1.2 Global Psychedelic Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Psychedelic Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PSYCHEDELIC DRUGS BY REGIONS
4.1 Psychedelic Drugs Market Size by Regions (2018-2023)
4.2 Americas Psychedelic Drugs Market Size Growth (2018-2023)
4.3 APAC Psychedelic Drugs Market Size Growth (2018-2023)
4.4 Europe Psychedelic Drugs Market Size Growth (2018-2023)
4.5 Middle East & Africa Psychedelic Drugs Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Psychedelic Drugs Market Size by Country (2018-2023)
5.2 Americas Psychedelic Drugs Market Size by Type (2018-2023)
5.3 Americas Psychedelic Drugs Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psychedelic Drugs Market Size by Region (2018-2023)
6.2 APAC Psychedelic Drugs Market Size by Type (2018-2023)
6.3 APAC Psychedelic Drugs Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Psychedelic Drugs by Country (2018-2023)
7.2 Europe Psychedelic Drugs Market Size by Type (2018-2023)
7.3 Europe Psychedelic Drugs Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psychedelic Drugs by Region (2018-2023)
8.2 Middle East & Africa Psychedelic Drugs Market Size by Type (2018-2023)
8.3 Middle East & Africa Psychedelic Drugs Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PSYCHEDELIC DRUGS MARKET FORECAST
10.1 Global Psychedelic Drugs Forecast by Regions (2024-2029)
10.1.1 Global Psychedelic Drugs Forecast by Regions (2024-2029)
10.1.2 Americas Psychedelic Drugs Forecast
10.1.3 APAC Psychedelic Drugs Forecast
10.1.4 Europe Psychedelic Drugs Forecast
10.1.5 Middle East & Africa Psychedelic Drugs Forecast
10.2 Americas Psychedelic Drugs Forecast by Country (2024-2029)
10.2.1 United States Psychedelic Drugs Market Forecast
10.2.2 Canada Psychedelic Drugs Market Forecast
10.2.3 Mexico Psychedelic Drugs Market Forecast
10.2.4 Brazil Psychedelic Drugs Market Forecast
10.3 APAC Psychedelic Drugs Forecast by Region (2024-2029)
10.3.1 China Psychedelic Drugs Market Forecast
10.3.2 Japan Psychedelic Drugs Market Forecast
10.3.3 Korea Psychedelic Drugs Market Forecast
10.3.4 Southeast Asia Psychedelic Drugs Market Forecast
10.3.5 India Psychedelic Drugs Market Forecast
10.3.6 Australia Psychedelic Drugs Market Forecast
10.4 Europe Psychedelic Drugs Forecast by Country (2024-2029)
10.4.1 Germany Psychedelic Drugs Market Forecast
10.4.2 France Psychedelic Drugs Market Forecast
10.4.3 UK Psychedelic Drugs Market Forecast
10.4.4 Italy Psychedelic Drugs Market Forecast
10.4.5 Russia Psychedelic Drugs Market Forecast
10.5 Middle East & Africa Psychedelic Drugs Forecast by Region (2024-2029)
10.5.1 Egypt Psychedelic Drugs Market Forecast
10.5.2 South Africa Psychedelic Drugs Market Forecast
10.5.3 Israel Psychedelic Drugs Market Forecast
10.5.4 Turkey Psychedelic Drugs Market Forecast
10.5.5 GCC Countries Psychedelic Drugs Market Forecast
10.6 Global Psychedelic Drugs Forecast by Type (2024-2029)
10.7 Global Psychedelic Drugs Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 COMPASS Pathways PLC
11.1.1 COMPASS Pathways PLC Company Information
11.1.2 COMPASS Pathways PLC Psychedelic Drugs Product Offered
11.1.3 COMPASS Pathways PLC Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 COMPASS Pathways PLC Main Business Overview
11.1.5 COMPASS Pathways PLC Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Psychedelic Drugs Product Offered
11.2.3 Pfizer Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Psychedelic Drugs Product Offered
11.3.3 Eli Lilly Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Eli Lilly Main Business Overview
11.3.5 Eli Lilly Latest Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Psychedelic Drugs Product Offered
11.4.3 GlaxoSmithKline Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 GlaxoSmithKline Main Business Overview
11.4.5 GlaxoSmithKline Latest Developments
11.5 Cybin Inc
11.5.1 Cybin Inc Company Information
11.5.2 Cybin Inc Psychedelic Drugs Product Offered
11.5.3 Cybin Inc Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Cybin Inc Main Business Overview
11.5.5 Cybin Inc Latest Developments
11.6 Field Trip Health
11.6.1 Field Trip Health Company Information
11.6.2 Field Trip Health Psychedelic Drugs Product Offered
11.6.3 Field Trip Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Field Trip Health Main Business Overview
11.6.5 Field Trip Health Latest Developments
11.7 ATAI Life Sciences
11.7.1 ATAI Life Sciences Company Information
11.7.2 ATAI Life Sciences Psychedelic Drugs Product Offered
11.7.3 ATAI Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 ATAI Life Sciences Main Business Overview
11.7.5 ATAI Life Sciences Latest Developments
11.8 NUMINUS WELLNESS
11.8.1 NUMINUS WELLNESS Company Information
11.8.2 NUMINUS WELLNESS Psychedelic Drugs Product Offered
11.8.3 NUMINUS WELLNESS Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 NUMINUS WELLNESS Main Business Overview
11.8.5 NUMINUS WELLNESS Latest Developments
11.9 MindMed
11.9.1 MindMed Company Information
11.9.2 MindMed Psychedelic Drugs Product Offered
11.9.3 MindMed Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 MindMed Main Business Overview
11.9.5 MindMed Latest Developments
11.10 HAVN Life Sciences
11.10.1 HAVN Life Sciences Company Information
11.10.2 HAVN Life Sciences Psychedelic Drugs Product Offered
11.10.3 HAVN Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 HAVN Life Sciences Main Business Overview
11.10.5 HAVN Life Sciences Latest Developments
11.11 Seelos Therapeutics
11.11.1 Seelos Therapeutics Company Information
11.11.2 Seelos Therapeutics Psychedelic Drugs Product Offered
11.11.3 Seelos Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Seelos Therapeutics Main Business Overview
11.11.5 Seelos Therapeutics Latest Developments
11.12 Jannsen
11.12.1 Jannsen Company Information
11.12.2 Jannsen Psychedelic Drugs Product Offered
11.12.3 Jannsen Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Jannsen Main Business Overview
11.12.5 Jannsen Latest Developments
11.13 Acadia Pharmaceuticals
11.13.1 Acadia Pharmaceuticals Company Information
11.13.2 Acadia Pharmaceuticals Psychedelic Drugs Product Offered
11.13.3 Acadia Pharmaceuticals Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Acadia Pharmaceuticals Main Business Overview
11.13.5 Acadia Pharmaceuticals Latest Developments
11.14 Intellipharmaceutics
11.14.1 Intellipharmaceutics Company Information
11.14.2 Intellipharmaceutics Psychedelic Drugs Product Offered
11.14.3 Intellipharmaceutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Intellipharmaceutics Main Business Overview
11.14.5 Intellipharmaceutics Latest Developments
11.15 Revive Therapeutics
11.15.1 Revive Therapeutics Company Information
11.15.2 Revive Therapeutics Psychedelic Drugs Product Offered
11.15.3 Revive Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Revive Therapeutics Main Business Overview
11.15.5 Revive Therapeutics Latest Developments
11.16 Mydecine Innovations Group
11.16.1 Mydecine Innovations Group Company Information
11.16.2 Mydecine Innovations Group Psychedelic Drugs Product Offered
11.16.3 Mydecine Innovations Group Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Mydecine Innovations Group Main Business Overview
11.16.5 Mydecine Innovations Group Latest Developments
11.17 Red Light Holland
11.17.1 Red Light Holland Company Information
11.17.2 Red Light Holland Psychedelic Drugs Product Offered
11.17.3 Red Light Holland Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Red Light Holland Main Business Overview
11.17.5 Red Light Holland Latest Developments
11.18 Braxia Scientific
11.18.1 Braxia Scientific Company Information
11.18.2 Braxia Scientific Psychedelic Drugs Product Offered
11.18.3 Braxia Scientific Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Braxia Scientific Main Business Overview
11.18.5 Braxia Scientific Latest Developments
11.19 Mind Cure Health
11.19.1 Mind Cure Health Company Information
11.19.2 Mind Cure Health Psychedelic Drugs Product Offered
11.19.3 Mind Cure Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Mind Cure Health Main Business Overview
11.19.5 Mind Cure Health Latest Developments
11.20 Entheon Biomedical
11.20.1 Entheon Biomedical Company Information
11.20.2 Entheon Biomedical Psychedelic Drugs Product Offered
11.20.3 Entheon Biomedical Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Entheon Biomedical Main Business Overview
11.20.5 Entheon Biomedical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psychedelic Drugs Market Size 2018-2029
2.1.2 Psychedelic Drugs Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Psychedelic Drugs Segment by Type
2.2.1 Psilocybin
2.2.2 LSD
2.2.3 MDMA
2.2.4 DMT
2.2.5 Ketamine
2.2.6 Others
2.3 Psychedelic Drugs Market Size by Type
2.3.1 Psychedelic Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Psychedelic Drugs Market Size Market Share by Type (2018-2023)
2.4 Psychedelic Drugs Segment by Application
2.4.1 Depressive Disorders
2.4.2 Post-Traumatic Stress Disorders
2.4.3 Substance Abuse Disorders
2.4.4 Obsessive Compulsive Disorders
2.4.5 Others
2.5 Psychedelic Drugs Market Size by Application
2.5.1 Psychedelic Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Psychedelic Drugs Market Size Market Share by Application (2018-2023)
3 PSYCHEDELIC DRUGS MARKET SIZE BY PLAYER
3.1 Psychedelic Drugs Market Size Market Share by Players
3.1.1 Global Psychedelic Drugs Revenue by Players (2018-2023)
3.1.2 Global Psychedelic Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Psychedelic Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PSYCHEDELIC DRUGS BY REGIONS
4.1 Psychedelic Drugs Market Size by Regions (2018-2023)
4.2 Americas Psychedelic Drugs Market Size Growth (2018-2023)
4.3 APAC Psychedelic Drugs Market Size Growth (2018-2023)
4.4 Europe Psychedelic Drugs Market Size Growth (2018-2023)
4.5 Middle East & Africa Psychedelic Drugs Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Psychedelic Drugs Market Size by Country (2018-2023)
5.2 Americas Psychedelic Drugs Market Size by Type (2018-2023)
5.3 Americas Psychedelic Drugs Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psychedelic Drugs Market Size by Region (2018-2023)
6.2 APAC Psychedelic Drugs Market Size by Type (2018-2023)
6.3 APAC Psychedelic Drugs Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Psychedelic Drugs by Country (2018-2023)
7.2 Europe Psychedelic Drugs Market Size by Type (2018-2023)
7.3 Europe Psychedelic Drugs Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psychedelic Drugs by Region (2018-2023)
8.2 Middle East & Africa Psychedelic Drugs Market Size by Type (2018-2023)
8.3 Middle East & Africa Psychedelic Drugs Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PSYCHEDELIC DRUGS MARKET FORECAST
10.1 Global Psychedelic Drugs Forecast by Regions (2024-2029)
10.1.1 Global Psychedelic Drugs Forecast by Regions (2024-2029)
10.1.2 Americas Psychedelic Drugs Forecast
10.1.3 APAC Psychedelic Drugs Forecast
10.1.4 Europe Psychedelic Drugs Forecast
10.1.5 Middle East & Africa Psychedelic Drugs Forecast
10.2 Americas Psychedelic Drugs Forecast by Country (2024-2029)
10.2.1 United States Psychedelic Drugs Market Forecast
10.2.2 Canada Psychedelic Drugs Market Forecast
10.2.3 Mexico Psychedelic Drugs Market Forecast
10.2.4 Brazil Psychedelic Drugs Market Forecast
10.3 APAC Psychedelic Drugs Forecast by Region (2024-2029)
10.3.1 China Psychedelic Drugs Market Forecast
10.3.2 Japan Psychedelic Drugs Market Forecast
10.3.3 Korea Psychedelic Drugs Market Forecast
10.3.4 Southeast Asia Psychedelic Drugs Market Forecast
10.3.5 India Psychedelic Drugs Market Forecast
10.3.6 Australia Psychedelic Drugs Market Forecast
10.4 Europe Psychedelic Drugs Forecast by Country (2024-2029)
10.4.1 Germany Psychedelic Drugs Market Forecast
10.4.2 France Psychedelic Drugs Market Forecast
10.4.3 UK Psychedelic Drugs Market Forecast
10.4.4 Italy Psychedelic Drugs Market Forecast
10.4.5 Russia Psychedelic Drugs Market Forecast
10.5 Middle East & Africa Psychedelic Drugs Forecast by Region (2024-2029)
10.5.1 Egypt Psychedelic Drugs Market Forecast
10.5.2 South Africa Psychedelic Drugs Market Forecast
10.5.3 Israel Psychedelic Drugs Market Forecast
10.5.4 Turkey Psychedelic Drugs Market Forecast
10.5.5 GCC Countries Psychedelic Drugs Market Forecast
10.6 Global Psychedelic Drugs Forecast by Type (2024-2029)
10.7 Global Psychedelic Drugs Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 COMPASS Pathways PLC
11.1.1 COMPASS Pathways PLC Company Information
11.1.2 COMPASS Pathways PLC Psychedelic Drugs Product Offered
11.1.3 COMPASS Pathways PLC Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 COMPASS Pathways PLC Main Business Overview
11.1.5 COMPASS Pathways PLC Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Psychedelic Drugs Product Offered
11.2.3 Pfizer Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Psychedelic Drugs Product Offered
11.3.3 Eli Lilly Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Eli Lilly Main Business Overview
11.3.5 Eli Lilly Latest Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Psychedelic Drugs Product Offered
11.4.3 GlaxoSmithKline Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 GlaxoSmithKline Main Business Overview
11.4.5 GlaxoSmithKline Latest Developments
11.5 Cybin Inc
11.5.1 Cybin Inc Company Information
11.5.2 Cybin Inc Psychedelic Drugs Product Offered
11.5.3 Cybin Inc Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Cybin Inc Main Business Overview
11.5.5 Cybin Inc Latest Developments
11.6 Field Trip Health
11.6.1 Field Trip Health Company Information
11.6.2 Field Trip Health Psychedelic Drugs Product Offered
11.6.3 Field Trip Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Field Trip Health Main Business Overview
11.6.5 Field Trip Health Latest Developments
11.7 ATAI Life Sciences
11.7.1 ATAI Life Sciences Company Information
11.7.2 ATAI Life Sciences Psychedelic Drugs Product Offered
11.7.3 ATAI Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 ATAI Life Sciences Main Business Overview
11.7.5 ATAI Life Sciences Latest Developments
11.8 NUMINUS WELLNESS
11.8.1 NUMINUS WELLNESS Company Information
11.8.2 NUMINUS WELLNESS Psychedelic Drugs Product Offered
11.8.3 NUMINUS WELLNESS Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 NUMINUS WELLNESS Main Business Overview
11.8.5 NUMINUS WELLNESS Latest Developments
11.9 MindMed
11.9.1 MindMed Company Information
11.9.2 MindMed Psychedelic Drugs Product Offered
11.9.3 MindMed Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 MindMed Main Business Overview
11.9.5 MindMed Latest Developments
11.10 HAVN Life Sciences
11.10.1 HAVN Life Sciences Company Information
11.10.2 HAVN Life Sciences Psychedelic Drugs Product Offered
11.10.3 HAVN Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 HAVN Life Sciences Main Business Overview
11.10.5 HAVN Life Sciences Latest Developments
11.11 Seelos Therapeutics
11.11.1 Seelos Therapeutics Company Information
11.11.2 Seelos Therapeutics Psychedelic Drugs Product Offered
11.11.3 Seelos Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Seelos Therapeutics Main Business Overview
11.11.5 Seelos Therapeutics Latest Developments
11.12 Jannsen
11.12.1 Jannsen Company Information
11.12.2 Jannsen Psychedelic Drugs Product Offered
11.12.3 Jannsen Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Jannsen Main Business Overview
11.12.5 Jannsen Latest Developments
11.13 Acadia Pharmaceuticals
11.13.1 Acadia Pharmaceuticals Company Information
11.13.2 Acadia Pharmaceuticals Psychedelic Drugs Product Offered
11.13.3 Acadia Pharmaceuticals Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Acadia Pharmaceuticals Main Business Overview
11.13.5 Acadia Pharmaceuticals Latest Developments
11.14 Intellipharmaceutics
11.14.1 Intellipharmaceutics Company Information
11.14.2 Intellipharmaceutics Psychedelic Drugs Product Offered
11.14.3 Intellipharmaceutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Intellipharmaceutics Main Business Overview
11.14.5 Intellipharmaceutics Latest Developments
11.15 Revive Therapeutics
11.15.1 Revive Therapeutics Company Information
11.15.2 Revive Therapeutics Psychedelic Drugs Product Offered
11.15.3 Revive Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Revive Therapeutics Main Business Overview
11.15.5 Revive Therapeutics Latest Developments
11.16 Mydecine Innovations Group
11.16.1 Mydecine Innovations Group Company Information
11.16.2 Mydecine Innovations Group Psychedelic Drugs Product Offered
11.16.3 Mydecine Innovations Group Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Mydecine Innovations Group Main Business Overview
11.16.5 Mydecine Innovations Group Latest Developments
11.17 Red Light Holland
11.17.1 Red Light Holland Company Information
11.17.2 Red Light Holland Psychedelic Drugs Product Offered
11.17.3 Red Light Holland Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Red Light Holland Main Business Overview
11.17.5 Red Light Holland Latest Developments
11.18 Braxia Scientific
11.18.1 Braxia Scientific Company Information
11.18.2 Braxia Scientific Psychedelic Drugs Product Offered
11.18.3 Braxia Scientific Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Braxia Scientific Main Business Overview
11.18.5 Braxia Scientific Latest Developments
11.19 Mind Cure Health
11.19.1 Mind Cure Health Company Information
11.19.2 Mind Cure Health Psychedelic Drugs Product Offered
11.19.3 Mind Cure Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Mind Cure Health Main Business Overview
11.19.5 Mind Cure Health Latest Developments
11.20 Entheon Biomedical
11.20.1 Entheon Biomedical Company Information
11.20.2 Entheon Biomedical Psychedelic Drugs Product Offered
11.20.3 Entheon Biomedical Psychedelic Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Entheon Biomedical Main Business Overview
11.20.5 Entheon Biomedical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Psychedelic Drugs Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Psilocybin
Table 3. Major Players of LSD
Table 4. Major Players of MDMA
Table 5. Major Players of DMT
Table 6. Major Players of Ketamine
Table 7. Major Players of Others
Table 8. Psychedelic Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Psychedelic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 10. Global Psychedelic Drugs Market Size Market Share by Type (2018-2023)
Table 11. Psychedelic Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 12. Global Psychedelic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 13. Global Psychedelic Drugs Market Size Market Share by Application (2018-2023)
Table 14. Global Psychedelic Drugs Revenue by Players (2018-2023) & ($ Millions)
Table 15. Global Psychedelic Drugs Revenue Market Share by Player (2018-2023)
Table 16. Psychedelic Drugs Key Players Head office and Products Offered
Table 17. Psychedelic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Psychedelic Drugs Market Size by Regions 2018-2023 & ($ Millions)
Table 21. Global Psychedelic Drugs Market Size Market Share by Regions (2018-2023)
Table 22. Global Psychedelic Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 23. Global Psychedelic Drugs Revenue Market Share by Country/Region (2018-2023)
Table 24. Americas Psychedelic Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 25. Americas Psychedelic Drugs Market Size Market Share by Country (2018-2023)
Table 26. Americas Psychedelic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 27. Americas Psychedelic Drugs Market Size Market Share by Type (2018-2023)
Table 28. Americas Psychedelic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 29. Americas Psychedelic Drugs Market Size Market Share by Application (2018-2023)
Table 30. APAC Psychedelic Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 31. APAC Psychedelic Drugs Market Size Market Share by Region (2018-2023)
Table 32. APAC Psychedelic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 33. APAC Psychedelic Drugs Market Size Market Share by Type (2018-2023)
Table 34. APAC Psychedelic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 35. APAC Psychedelic Drugs Market Size Market Share by Application (2018-2023)
Table 36. Europe Psychedelic Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 37. Europe Psychedelic Drugs Market Size Market Share by Country (2018-2023)
Table 38. Europe Psychedelic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 39. Europe Psychedelic Drugs Market Size Market Share by Type (2018-2023)
Table 40. Europe Psychedelic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 41. Europe Psychedelic Drugs Market Size Market Share by Application (2018-2023)
Table 42. Middle East & Africa Psychedelic Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Psychedelic Drugs Market Size Market Share by Region (2018-2023)
Table 44. Middle East & Africa Psychedelic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Psychedelic Drugs Market Size Market Share by Type (2018-2023)
Table 46. Middle East & Africa Psychedelic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 47. Middle East & Africa Psychedelic Drugs Market Size Market Share by Application (2018-2023)
Table 48. Key Market Drivers & Growth Opportunities of Psychedelic Drugs
Table 49. Key Market Challenges & Risks of Psychedelic Drugs
Table 50. Key Industry Trends of Psychedelic Drugs
Table 51. Global Psychedelic Drugs Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 52. Global Psychedelic Drugs Market Size Market Share Forecast by Regions (2024-2029)
Table 53. Global Psychedelic Drugs Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 54. Global Psychedelic Drugs Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 55. COMPASS Pathways PLC Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 56. COMPASS Pathways PLC Psychedelic Drugs Product Offered
Table 57. COMPASS Pathways PLC Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 58. COMPASS Pathways PLC Main Business
Table 59. COMPASS Pathways PLC Latest Developments
Table 60. Pfizer Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 61. Pfizer Psychedelic Drugs Product Offered
Table 62. Pfizer Main Business
Table 63. Pfizer Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 64. Pfizer Latest Developments
Table 65. Eli Lilly Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 66. Eli Lilly Psychedelic Drugs Product Offered
Table 67. Eli Lilly Main Business
Table 68. Eli Lilly Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 69. Eli Lilly Latest Developments
Table 70. GlaxoSmithKline Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 71. GlaxoSmithKline Psychedelic Drugs Product Offered
Table 72. GlaxoSmithKline Main Business
Table 73. GlaxoSmithKline Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 74. GlaxoSmithKline Latest Developments
Table 75. Cybin Inc Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 76. Cybin Inc Psychedelic Drugs Product Offered
Table 77. Cybin Inc Main Business
Table 78. Cybin Inc Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 79. Cybin Inc Latest Developments
Table 80. Field Trip Health Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 81. Field Trip Health Psychedelic Drugs Product Offered
Table 82. Field Trip Health Main Business
Table 83. Field Trip Health Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 84. Field Trip Health Latest Developments
Table 85. ATAI Life Sciences Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 86. ATAI Life Sciences Psychedelic Drugs Product Offered
Table 87. ATAI Life Sciences Main Business
Table 88. ATAI Life Sciences Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 89. ATAI Life Sciences Latest Developments
Table 90. NUMINUS WELLNESS Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 91. NUMINUS WELLNESS Psychedelic Drugs Product Offered
Table 92. NUMINUS WELLNESS Main Business
Table 93. NUMINUS WELLNESS Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 94. NUMINUS WELLNESS Latest Developments
Table 95. MindMed Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 96. MindMed Psychedelic Drugs Product Offered
Table 97. MindMed Main Business
Table 98. MindMed Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 99. MindMed Latest Developments
Table 100. HAVN Life Sciences Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 101. HAVN Life Sciences Psychedelic Drugs Product Offered
Table 102. HAVN Life Sciences Main Business
Table 103. HAVN Life Sciences Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. HAVN Life Sciences Latest Developments
Table 105. Seelos Therapeutics Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 106. Seelos Therapeutics Psychedelic Drugs Product Offered
Table 107. Seelos Therapeutics Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 108. Seelos Therapeutics Main Business
Table 109. Seelos Therapeutics Latest Developments
Table 110. Jannsen Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 111. Jannsen Psychedelic Drugs Product Offered
Table 112. Jannsen Main Business
Table 113. Jannsen Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 114. Jannsen Latest Developments
Table 115. Acadia Pharmaceuticals Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 116. Acadia Pharmaceuticals Psychedelic Drugs Product Offered
Table 117. Acadia Pharmaceuticals Main Business
Table 118. Acadia Pharmaceuticals Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 119. Acadia Pharmaceuticals Latest Developments
Table 120. Intellipharmaceutics Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 121. Intellipharmaceutics Psychedelic Drugs Product Offered
Table 122. Intellipharmaceutics Main Business
Table 123. Intellipharmaceutics Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 124. Intellipharmaceutics Latest Developments
Table 125. Revive Therapeutics Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 126. Revive Therapeutics Psychedelic Drugs Product Offered
Table 127. Revive Therapeutics Main Business
Table 128. Revive Therapeutics Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 129. Revive Therapeutics Latest Developments
Table 130. Mydecine Innovations Group Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 131. Mydecine Innovations Group Psychedelic Drugs Product Offered
Table 132. Mydecine Innovations Group Main Business
Table 133. Mydecine Innovations Group Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 134. Mydecine Innovations Group Latest Developments
Table 135. Red Light Holland Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 136. Red Light Holland Psychedelic Drugs Product Offered
Table 137. Red Light Holland Main Business
Table 138. Red Light Holland Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 139. Red Light Holland Latest Developments
Table 140. Braxia Scientific Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 141. Braxia Scientific Psychedelic Drugs Product Offered
Table 142. Braxia Scientific Main Business
Table 143. Braxia Scientific Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 144. Braxia Scientific Latest Developments
Table 145. Mind Cure Health Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 146. Mind Cure Health Psychedelic Drugs Product Offered
Table 147. Mind Cure Health Main Business
Table 148. Mind Cure Health Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 149. Mind Cure Health Latest Developments
Table 150. Entheon Biomedical Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 151. Entheon Biomedical Psychedelic Drugs Product Offered
Table 152. Entheon Biomedical Main Business
Table 153. Entheon Biomedical Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 154. Entheon Biomedical Latest Developments
Table 1. Psychedelic Drugs Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Psilocybin
Table 3. Major Players of LSD
Table 4. Major Players of MDMA
Table 5. Major Players of DMT
Table 6. Major Players of Ketamine
Table 7. Major Players of Others
Table 8. Psychedelic Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Psychedelic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 10. Global Psychedelic Drugs Market Size Market Share by Type (2018-2023)
Table 11. Psychedelic Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 12. Global Psychedelic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 13. Global Psychedelic Drugs Market Size Market Share by Application (2018-2023)
Table 14. Global Psychedelic Drugs Revenue by Players (2018-2023) & ($ Millions)
Table 15. Global Psychedelic Drugs Revenue Market Share by Player (2018-2023)
Table 16. Psychedelic Drugs Key Players Head office and Products Offered
Table 17. Psychedelic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Psychedelic Drugs Market Size by Regions 2018-2023 & ($ Millions)
Table 21. Global Psychedelic Drugs Market Size Market Share by Regions (2018-2023)
Table 22. Global Psychedelic Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 23. Global Psychedelic Drugs Revenue Market Share by Country/Region (2018-2023)
Table 24. Americas Psychedelic Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 25. Americas Psychedelic Drugs Market Size Market Share by Country (2018-2023)
Table 26. Americas Psychedelic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 27. Americas Psychedelic Drugs Market Size Market Share by Type (2018-2023)
Table 28. Americas Psychedelic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 29. Americas Psychedelic Drugs Market Size Market Share by Application (2018-2023)
Table 30. APAC Psychedelic Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 31. APAC Psychedelic Drugs Market Size Market Share by Region (2018-2023)
Table 32. APAC Psychedelic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 33. APAC Psychedelic Drugs Market Size Market Share by Type (2018-2023)
Table 34. APAC Psychedelic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 35. APAC Psychedelic Drugs Market Size Market Share by Application (2018-2023)
Table 36. Europe Psychedelic Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 37. Europe Psychedelic Drugs Market Size Market Share by Country (2018-2023)
Table 38. Europe Psychedelic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 39. Europe Psychedelic Drugs Market Size Market Share by Type (2018-2023)
Table 40. Europe Psychedelic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 41. Europe Psychedelic Drugs Market Size Market Share by Application (2018-2023)
Table 42. Middle East & Africa Psychedelic Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Psychedelic Drugs Market Size Market Share by Region (2018-2023)
Table 44. Middle East & Africa Psychedelic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Psychedelic Drugs Market Size Market Share by Type (2018-2023)
Table 46. Middle East & Africa Psychedelic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 47. Middle East & Africa Psychedelic Drugs Market Size Market Share by Application (2018-2023)
Table 48. Key Market Drivers & Growth Opportunities of Psychedelic Drugs
Table 49. Key Market Challenges & Risks of Psychedelic Drugs
Table 50. Key Industry Trends of Psychedelic Drugs
Table 51. Global Psychedelic Drugs Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 52. Global Psychedelic Drugs Market Size Market Share Forecast by Regions (2024-2029)
Table 53. Global Psychedelic Drugs Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 54. Global Psychedelic Drugs Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 55. COMPASS Pathways PLC Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 56. COMPASS Pathways PLC Psychedelic Drugs Product Offered
Table 57. COMPASS Pathways PLC Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 58. COMPASS Pathways PLC Main Business
Table 59. COMPASS Pathways PLC Latest Developments
Table 60. Pfizer Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 61. Pfizer Psychedelic Drugs Product Offered
Table 62. Pfizer Main Business
Table 63. Pfizer Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 64. Pfizer Latest Developments
Table 65. Eli Lilly Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 66. Eli Lilly Psychedelic Drugs Product Offered
Table 67. Eli Lilly Main Business
Table 68. Eli Lilly Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 69. Eli Lilly Latest Developments
Table 70. GlaxoSmithKline Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 71. GlaxoSmithKline Psychedelic Drugs Product Offered
Table 72. GlaxoSmithKline Main Business
Table 73. GlaxoSmithKline Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 74. GlaxoSmithKline Latest Developments
Table 75. Cybin Inc Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 76. Cybin Inc Psychedelic Drugs Product Offered
Table 77. Cybin Inc Main Business
Table 78. Cybin Inc Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 79. Cybin Inc Latest Developments
Table 80. Field Trip Health Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 81. Field Trip Health Psychedelic Drugs Product Offered
Table 82. Field Trip Health Main Business
Table 83. Field Trip Health Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 84. Field Trip Health Latest Developments
Table 85. ATAI Life Sciences Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 86. ATAI Life Sciences Psychedelic Drugs Product Offered
Table 87. ATAI Life Sciences Main Business
Table 88. ATAI Life Sciences Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 89. ATAI Life Sciences Latest Developments
Table 90. NUMINUS WELLNESS Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 91. NUMINUS WELLNESS Psychedelic Drugs Product Offered
Table 92. NUMINUS WELLNESS Main Business
Table 93. NUMINUS WELLNESS Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 94. NUMINUS WELLNESS Latest Developments
Table 95. MindMed Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 96. MindMed Psychedelic Drugs Product Offered
Table 97. MindMed Main Business
Table 98. MindMed Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 99. MindMed Latest Developments
Table 100. HAVN Life Sciences Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 101. HAVN Life Sciences Psychedelic Drugs Product Offered
Table 102. HAVN Life Sciences Main Business
Table 103. HAVN Life Sciences Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. HAVN Life Sciences Latest Developments
Table 105. Seelos Therapeutics Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 106. Seelos Therapeutics Psychedelic Drugs Product Offered
Table 107. Seelos Therapeutics Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 108. Seelos Therapeutics Main Business
Table 109. Seelos Therapeutics Latest Developments
Table 110. Jannsen Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 111. Jannsen Psychedelic Drugs Product Offered
Table 112. Jannsen Main Business
Table 113. Jannsen Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 114. Jannsen Latest Developments
Table 115. Acadia Pharmaceuticals Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 116. Acadia Pharmaceuticals Psychedelic Drugs Product Offered
Table 117. Acadia Pharmaceuticals Main Business
Table 118. Acadia Pharmaceuticals Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 119. Acadia Pharmaceuticals Latest Developments
Table 120. Intellipharmaceutics Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 121. Intellipharmaceutics Psychedelic Drugs Product Offered
Table 122. Intellipharmaceutics Main Business
Table 123. Intellipharmaceutics Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 124. Intellipharmaceutics Latest Developments
Table 125. Revive Therapeutics Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 126. Revive Therapeutics Psychedelic Drugs Product Offered
Table 127. Revive Therapeutics Main Business
Table 128. Revive Therapeutics Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 129. Revive Therapeutics Latest Developments
Table 130. Mydecine Innovations Group Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 131. Mydecine Innovations Group Psychedelic Drugs Product Offered
Table 132. Mydecine Innovations Group Main Business
Table 133. Mydecine Innovations Group Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 134. Mydecine Innovations Group Latest Developments
Table 135. Red Light Holland Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 136. Red Light Holland Psychedelic Drugs Product Offered
Table 137. Red Light Holland Main Business
Table 138. Red Light Holland Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 139. Red Light Holland Latest Developments
Table 140. Braxia Scientific Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 141. Braxia Scientific Psychedelic Drugs Product Offered
Table 142. Braxia Scientific Main Business
Table 143. Braxia Scientific Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 144. Braxia Scientific Latest Developments
Table 145. Mind Cure Health Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 146. Mind Cure Health Psychedelic Drugs Product Offered
Table 147. Mind Cure Health Main Business
Table 148. Mind Cure Health Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 149. Mind Cure Health Latest Developments
Table 150. Entheon Biomedical Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 151. Entheon Biomedical Psychedelic Drugs Product Offered
Table 152. Entheon Biomedical Main Business
Table 153. Entheon Biomedical Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 154. Entheon Biomedical Latest Developments
LIST OF FIGURES
Figure 1. Psychedelic Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Psychedelic Drugs Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Psychedelic Drugs Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Psychedelic Drugs Sales Market Share by Country/Region (2022)
Figure 8. Psychedelic Drugs Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Psychedelic Drugs Market Size Market Share by Type in 2022
Figure 10. Psychedelic Drugs in Depressive Disorders
Figure 11. Global Psychedelic Drugs Market: Depressive Disorders (2018-2023) & ($ Millions)
Figure 12. Psychedelic Drugs in Post-Traumatic Stress Disorders
Figure 13. Global Psychedelic Drugs Market: Post-Traumatic Stress Disorders (2018-2023) & ($ Millions)
Figure 14. Psychedelic Drugs in Substance Abuse Disorders
Figure 15. Global Psychedelic Drugs Market: Substance Abuse Disorders (2018-2023) & ($ Millions)
Figure 16. Psychedelic Drugs in Obsessive Compulsive Disorders
Figure 17. Global Psychedelic Drugs Market: Obsessive Compulsive Disorders (2018-2023) & ($ Millions)
Figure 18. Psychedelic Drugs in Others
Figure 19. Global Psychedelic Drugs Market: Others (2018-2023) & ($ Millions)
Figure 20. Global Psychedelic Drugs Market Size Market Share by Application in 2022
Figure 21. Global Psychedelic Drugs Revenue Market Share by Player in 2022
Figure 22. Global Psychedelic Drugs Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Psychedelic Drugs Market Size 2018-2023 ($ Millions)
Figure 24. APAC Psychedelic Drugs Market Size 2018-2023 ($ Millions)
Figure 25. Europe Psychedelic Drugs Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Psychedelic Drugs Market Size 2018-2023 ($ Millions)
Figure 27. Americas Psychedelic Drugs Value Market Share by Country in 2022
Figure 28. United States Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Psychedelic Drugs Market Size Market Share by Region in 2022
Figure 33. APAC Psychedelic Drugs Market Size Market Share by Type in 2022
Figure 34. APAC Psychedelic Drugs Market Size Market Share by Application in 2022
Figure 35. China Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Psychedelic Drugs Market Size Market Share by Country in 2022
Figure 42. Europe Psychedelic Drugs Market Size Market Share by Type (2018-2023)
Figure 43. Europe Psychedelic Drugs Market Size Market Share by Application (2018-2023)
Figure 44. Germany Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Psychedelic Drugs Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Psychedelic Drugs Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Psychedelic Drugs Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 58. APAC Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 59. Europe Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 61. United States Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 62. Canada Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 65. China Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 66. Japan Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 67. Korea Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 69. India Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 70. Australia Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 71. Germany Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 72. France Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 73. UK Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 74. Italy Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 75. Russia Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 76. Spain Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 79. Israel Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 82. Global Psychedelic Drugs Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Psychedelic Drugs Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Psychedelic Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Psychedelic Drugs Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Psychedelic Drugs Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Psychedelic Drugs Sales Market Share by Country/Region (2022)
Figure 8. Psychedelic Drugs Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Psychedelic Drugs Market Size Market Share by Type in 2022
Figure 10. Psychedelic Drugs in Depressive Disorders
Figure 11. Global Psychedelic Drugs Market: Depressive Disorders (2018-2023) & ($ Millions)
Figure 12. Psychedelic Drugs in Post-Traumatic Stress Disorders
Figure 13. Global Psychedelic Drugs Market: Post-Traumatic Stress Disorders (2018-2023) & ($ Millions)
Figure 14. Psychedelic Drugs in Substance Abuse Disorders
Figure 15. Global Psychedelic Drugs Market: Substance Abuse Disorders (2018-2023) & ($ Millions)
Figure 16. Psychedelic Drugs in Obsessive Compulsive Disorders
Figure 17. Global Psychedelic Drugs Market: Obsessive Compulsive Disorders (2018-2023) & ($ Millions)
Figure 18. Psychedelic Drugs in Others
Figure 19. Global Psychedelic Drugs Market: Others (2018-2023) & ($ Millions)
Figure 20. Global Psychedelic Drugs Market Size Market Share by Application in 2022
Figure 21. Global Psychedelic Drugs Revenue Market Share by Player in 2022
Figure 22. Global Psychedelic Drugs Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Psychedelic Drugs Market Size 2018-2023 ($ Millions)
Figure 24. APAC Psychedelic Drugs Market Size 2018-2023 ($ Millions)
Figure 25. Europe Psychedelic Drugs Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Psychedelic Drugs Market Size 2018-2023 ($ Millions)
Figure 27. Americas Psychedelic Drugs Value Market Share by Country in 2022
Figure 28. United States Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Psychedelic Drugs Market Size Market Share by Region in 2022
Figure 33. APAC Psychedelic Drugs Market Size Market Share by Type in 2022
Figure 34. APAC Psychedelic Drugs Market Size Market Share by Application in 2022
Figure 35. China Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Psychedelic Drugs Market Size Market Share by Country in 2022
Figure 42. Europe Psychedelic Drugs Market Size Market Share by Type (2018-2023)
Figure 43. Europe Psychedelic Drugs Market Size Market Share by Application (2018-2023)
Figure 44. Germany Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Psychedelic Drugs Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Psychedelic Drugs Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Psychedelic Drugs Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Psychedelic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 58. APAC Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 59. Europe Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 61. United States Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 62. Canada Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 65. China Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 66. Japan Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 67. Korea Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 69. India Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 70. Australia Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 71. Germany Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 72. France Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 73. UK Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 74. Italy Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 75. Russia Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 76. Spain Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 79. Israel Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Psychedelic Drugs Market Size 2024-2029 ($ Millions)
Figure 82. Global Psychedelic Drugs Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Psychedelic Drugs Market Size Market Share Forecast by Application (2024-2029)
